A detailed history of International Assets Investment Management, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 287,287 shares of ALDX stock, worth $1.37 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
287,287
Previous 57,800 397.04%
Holding current value
$1.37 Million
Previous $191 Million 72.14%
% of portfolio
0.15%
Previous 0.02%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$3.19 - $6.32 $732,063 - $1.45 Million
229,487 Added 397.04%
287,287 $53.3 Million
Q2 2024

Jul 30, 2024

SELL
$3.25 - $4.72 $8,125 - $11,800
-2,500 Reduced 4.15%
57,800 $191 Million
Q1 2024

Apr 11, 2024

BUY
$2.77 - $4.22 $4,986 - $7,596
1,800 Added 3.08%
60,300 $197 Million
Q4 2023

Jan 25, 2024

SELL
$1.47 - $6.06 $215,847 - $889,820
-146,835 Reduced 71.51%
58,500 $205,000
Q4 2023

Jan 24, 2024

BUY
$1.47 - $6.06 $229,838 - $947,499
156,353 Added 319.21%
205,335 $58.5 Million
Q3 2023

Oct 04, 2023

BUY
$6.11 - $8.16 $4,246 - $5,671
695 Added 1.44%
48,982 $327,000
Q2 2023

Jul 20, 2023

SELL
$7.11 - $11.89 $135,836 - $227,158
-19,105 Reduced 28.35%
48,287 $405,000
Q1 2023

Apr 19, 2023

BUY
$5.77 - $9.93 $26,455 - $45,529
4,585 Added 7.3%
67,392 $669,000
Q4 2022

Jan 30, 2023

BUY
$5.08 - $7.09 $319,059 - $445,301
62,807 New
62,807 $437,000
Q3 2022

Oct 31, 2022

SELL
$3.8 - $7.74 $2,272 - $4,628
-598 Reduced 1.0%
59,277 $317,000
Q2 2022

Aug 17, 2022

BUY
$2.43 - $4.85 $6,682 - $13,337
2,750 Added 4.81%
59,875 $239,000
Q1 2022

May 03, 2022

BUY
$3.25 - $5.17 $22,100 - $35,156
6,800 Added 13.51%
57,125 $254,000
Q4 2021

Jan 21, 2022

BUY
$3.5 - $9.63 $28,437 - $78,243
8,125 Added 19.25%
50,325 $201,000
Q3 2021

Oct 28, 2021

BUY
$7.94 - $11.31 $118,504 - $168,801
14,925 Added 54.72%
42,200 $371,000
Q2 2021

Jul 14, 2021

SELL
$10.44 - $14.85 $105,235 - $149,688
-10,080 Reduced 26.98%
27,275 $309,000
Q1 2021

Apr 19, 2021

BUY
$6.53 - $14.42 $65,561 - $144,776
10,040 Added 36.76%
37,355 $306,000
Q4 2020

Jan 22, 2021

BUY
$6.31 - $8.13 $172,357 - $222,070
27,315 New
27,315 $187 Million

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $278M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.